Mississauga, ON -- (SBWIRE) -- 12/01/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "MabVax Files IND With The FDA, Shares Up On News."
Companies mentioned in this article include MabVax Therapeutics Holdings Inc. (OTCQB:MBVX).
Article Excerpt:
According to a report by IMS Health earlier this year, global spending on cancer medicines reached $100 billion in 2014. In 2014, spending on cancer drugs accounted for more than 10% of all drug spending worldwide.
IMS expects spending on cancer drugs to rise to between $117 billion and $147 billion by 2018. Much of the increase in spending on oncology drugs is being driven by the availability of new treatment options. It's safe to say that cancer research is a hot area in the biotech space.
Pancreatic cancer is a severely underserved area. By the end of this year, the worldwide pancreatic cancer treatment market is expected to be worth $1.2 billion, according to Transparency Market Research. In the U.S. alone, some 30,000 patients are diagnosed with pancreatic cancer each year. Transparency Market Research notes in its report on the global pancreatic cancer treatment market that it has among the highest unmet therapy needs in the overall oncology market.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/592/mabvax-files-ind-with-the-fda-shares-up-on-news.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.